DocGo Inc (DCGO)
3.085
-0.12
(-3.59%)
USD |
NASDAQ |
May 17, 16:00
3.085
0.00 (0.00%)
After-Hours: 20:00
DocGo Enterprise Value: 305.39M for May 17, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
May 17, 2024 | 305.39M |
May 16, 2024 | 317.58M |
May 15, 2024 | 333.83M |
May 14, 2024 | 327.73M |
May 13, 2024 | 313.51M |
May 10, 2024 | 299.30M |
May 09, 2024 | 304.88M |
May 08, 2024 | 348.05M |
May 07, 2024 | 354.14M |
May 06, 2024 | 368.36M |
May 03, 2024 | 360.89M |
May 02, 2024 | 350.69M |
May 01, 2024 | 338.45M |
April 30, 2024 | 337.43M |
April 29, 2024 | 361.91M |
April 26, 2024 | 360.89M |
April 25, 2024 | 348.65M |
April 24, 2024 | 351.71M |
April 23, 2024 | 349.67M |
April 22, 2024 | 350.69M |
April 19, 2024 | 356.81M |
April 18, 2024 | 344.70M |
April 17, 2024 | 338.52M |
April 16, 2024 | 328.22M |
April 15, 2024 | 327.19M |
Date | Value |
---|---|
April 12, 2024 | 328.22M |
April 11, 2024 | 338.00M |
April 10, 2024 | 337.49M |
April 09, 2024 | 388.97M |
April 08, 2024 | 381.76M |
April 05, 2024 | 384.85M |
April 04, 2024 | 384.85M |
April 03, 2024 | 386.91M |
April 02, 2024 | 384.85M |
April 01, 2024 | 408.53M |
March 31, 2024 | 408.53M |
March 28, 2024 | 391.01M |
March 27, 2024 | 393.10M |
March 26, 2024 | 375.39M |
March 25, 2024 | 382.68M |
March 22, 2024 | 372.26M |
March 21, 2024 | 381.64M |
March 20, 2024 | 388.93M |
March 19, 2024 | 396.22M |
March 18, 2024 | 353.51M |
March 15, 2024 | 351.43M |
March 14, 2024 | 341.01M |
March 13, 2024 | 334.76M |
March 12, 2024 | 348.30M |
March 11, 2024 | 364.97M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
281.28M
Minimum
Jan 10 2024
992.98M
Maximum
Nov 08 2021
637.81M
Average
606.89M
Median
Jun 17 2022
Enterprise Value Benchmarks
American Shared Hospital Services | 29.20M |
Novo Integrated Sciences Inc | 11.48M |
Astrana Health Inc | 1.709B |
Cryo-Cell International Inc | 82.49M |
P3 Health Partners Inc | 403.41M |
Enterprise Value Related Metrics
Net Income (Quarterly) | 11.23M |
Revenue (Quarterly) | 192.09M |
Total Expenses (Quarterly) | 176.21M |
EPS Diluted (Quarterly) | 0.10 |
Gross Profit Margin (Quarterly) | 35.02% |
Profit Margin (Quarterly) | 5.84% |
Earnings Yield | 6.58% |
Operating Earnings Yield | 11.44% |
Normalized Earnings Yield | 6.637 |